(Press-News.org) RENO, Nev. – A new, rapid blood test that could lead to early diagnosis and potentially save the lives of hundreds of thousands of people stricken with fungal meningitis, a leading cause of AIDS-related deaths in developing countries, is getting closer to market with a recent collaboration between the University of Nevada, Reno and Immuno-Mycologics (IMMY) in Oklahoma.
"The ability to quickly identify yeast infection in patients is expected to help in significantly reducing cryptococcal meningitis deaths in resource-limited countries such as those in sub-Saharan Africa," said Tom Kozel, professor of microbiology at the University of Nevada School of Medicine. "Cryptococcosis is a rare form of meningitis among otherwise healthy individuals, but an estimated 600,000 lives are lost to this infection each year in patients with AIDS. Many of these lives could be saved through early diagnosis."
If successful, the new field test to detect cryptococcal antigen will use a drop of blood from a finger-stick or a urine sample to immediately identify the presence of the disease so treatment can begin instantly, rather than having to wait for results to be processed at a lab. The point-of-care product is the result of a collaboration between Kozel and Sean Bauman, president and CEO of IMMY. The product is being developed under a licensing agreement established through the University's Technology Transfer Office and IMMY.
"We developed several antibodies to the fungus with the support of research funded by the National Institutes of Health," Kozel said. "IMMY needed an antibody that worked well with their idea for this new noninvasive procedure to introduce in developing countries where deaths are skyrocketing from HIV-related cryptococcal meningitis. We found fairly quickly that one of ours works very well."
Kozel developed the antibody used for the Cryptococcus test in his lab at the University of Nevada, Reno. Bauman commercialized the technology to make it available at low cost to patients in developing countries through IMMY, a market leader in diagnostics for fungal infections.
"One of the stipulations in our agreement for the licensing of the product with IMMY is to have this crucial test available at low cost," Ryan Heck, director of the University's Technology Transfer Office, said. "Dr. Bauman had already begun to make this happen on several avenues."
IMMY is using the antibody now for testing in Africa, but only through the traditional, time-consuming and expensive methods of venipuncture (blood draw) or spinal tap for cerebrospinal fluid. The team is working to get additional funding for studies needed to further develop and validate the new point-of-care product to make it readily available to patients.
We have submitted a version of the test that is designed for use with serum from a venipuncture or cerebrospinal fluid to the FDA for approval. We have received the CE mark, which allows sales in EU countries and many developing world countries," Bauman said. "We are already manufacturing and distributing the diagnostic for this use."
Modification of the test to a point-of-care format and clinical validation will be a major step toward meeting the World Health Organization's Global Access health requirements.
"With the point-of-care product, a health-care provider can give the test, observe the results and administer the first dose of oral medication, all within a few minutes," Kozel, who has been conducting AIDS research for more than 25 years, said. "Studies have shown early identification and treatment are essential to beat the disease; a late diagnosis means antifungal therapy will likely fail in resource-limited countries. Most patients in that setting are not diagnosed until they are very sick, and then it's too late."
Antifungals used to treat cryptococcosis are available for free or at low cost in regions such as sub-Saharan Africa. However, early diagnosis is crucial for successful drug therapy. Bauman saw this need and the staggering numbers of preventable deaths occurring in third-world countries, particularly in Africa, and decided to do something about it.
"As many as one in 10 AIDS patients in countries with limited infrastructure or resources may develop cryptococcal meningitis," Kozel said. "If we can diagnose early and begin treatment, we can save an amazing number of lives."
INFORMATION:
A short promotional video about the new Cryptococcus point-of-care product can be viewed at http://www.immy.com/?q=crypto_vid.
Nevada's land-grant university founded in 1874, the University of Nevada, Reno has an enrollment of more than 17,000 students. The University is home to one the country's largest study-abroad programs and the state's medical school, and offers outreach and education programs in all Nevada counties. For more information, visit www.unr.edu.
University of Nevada, Reno, teams with IMMY to make new life-saving blood test
New test hastens diagnosis for Cryptococcosis, top cause of HIV-related deaths in developing countries
2011-03-05
ELSE PRESS RELEASES FROM THIS DATE:
New microscope produces dazzling 3-D movies of live cells
2011-03-05
A new microscope invented by scientists at Howard Hughes Medical Institute's Janelia Farm Research Campus will let researchers use an exquisitely thin sheet of light -- similar to that used in supermarket bar-code scanners -- to peer inside single living cells, revealing the three-dimensional shapes of cellular landmarks in unprecedented detail. The microscopy technique images at high speed, so researchers can create dazzling movies that make biological processes, such as cell division, come alive.
The technique, called Bessel beam plane illumination microscopy, is described ...
Boosting protein garbage disposal in brain cells protects mice from Alzheimer's disease
2011-03-05
Washington, D.C. – Gene therapy that boosts the ability of brain cells to gobble up toxic proteins prevents development of Alzheimer's disease in mice that are predestined to develop it, report researchers at Georgetown University Medical Center. They say the treatment – which is given just once - could potentially do the same in people at the beginning stages of the disease.
The study, published online in Human Molecular Genetics, demonstrates that giving brain cells extra parkin genes promotes efficient and effective removal of amyloid particles believed to be destroying ...
Supercritical carbon dioxide Brayton Cycle turbines promise giant leap
2011-03-05
ALBUQUERQUE, N.M. — Sandia National Laboratories researchers are moving into the demonstration phase of a novel gas turbine system for power generation, with the promise that thermal-to-electric conversion efficiency will be increased to as much as 50 percent — an improvement of 50 percent for nuclear power stations equipped with steam turbines, or a 40 percent improvement for simple gas turbines. The system is also very compact, meaning that capital costs would be relatively low.
Research focuses on supercritical carbon dioxide (S-CO2) Brayton-cycle turbines, which typically ...
Sink or source? A new model to measure organic carbon in surface waters
2011-03-05
A new carbon model allows scientists to estimate sources and losses of organic carbon in surface waters in the United States. Study results indicate that streams act as both sources and sinks for organic carbon.
"Model estimates help managers and researchers track carbon transport in streams, which is information that is ultimately needed to improve our understanding of the fate of rising carbon dioxide levels in the atmosphere," said Dr. Richard Smith, a USGS hydrologist and coauthor of the study. "The study contributes new information on the role of rivers as sources ...
Vaccinated children not at higher risk of infections or allergic diseases
2011-03-05
May vaccinations put too much strain on or weaken children's immune systems and are therefore harmful? Roma Schmitz and her colleagues from the Robert Koch Institute investigate exactly this research question in the current issue of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2011; 108(7): 105-11). Their data are based on the results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS).
In their study, the authors compare the occurrence of infections and allergies in vaccinated and unvaccinated children and adolescents. These ...
The better off sleep better
2011-03-05
Analysis of the early data from Understanding Society based on 14,000 UK households found that overall the best sleep was reported by people with higher levels of education and by married people. The type of work a person does also impacts on sleep, with those in routine occupations reporting worse sleep than those in professional occupations.
Professor Sara Arber at the University of Surrey who analysed the findings said: "Given the links between sleep, social and economic circumstances and poor health found in this and other surveys, health promotion campaigns should ...
The scars of impacts on Mars
2011-03-05
ESA's Mars Express has returned new images of an elongated impact crater in the southern hemisphere of Mars. Located just south of the Huygens basin, it could have been carved out by a train of projectiles striking the planet at a shallow angle.
The large Huygens basin (not visible in the main image but seen in the wider contextual image) is about 450 km in diameter and lies in the heavily cratered southern highlands. In this area there are many impact scars but none perhaps are more intriguing than the 'elongated craters'.
One of these craters is seen in this new image, ...
Zooming in on the weapons of Salmonella
2011-03-05
Some of the most dreaded diseases in the world such as plague, typhoid and cholera are caused by bacteria that have one thing in common: they possess an infection apparatus which is a nearly unbeatable weapon. When attacking a cell of the body, they develop numerous hollow-needle-shaped structures that project from the bacterial surface. Through these needles, the bacteria inject signal substances into the host cells, which re-program the latter and thereby overcome their defense. From this time on it's easy game for the pathogens; they can invade the cells unimpeded and ...
BNCT, a new-generation radiation treatment, is effective in advanced head and neck cancer
2011-03-05
Biologically targeted BNCT treatment is based on producing radiation inside a tumour using
boron-10 and thermal neutrons. Boron-10 is introduced into cancer cells with the help of a special carrier substance (phenylalanine), after which the tumour is irradiated with lowenergy neutrons. The latter react with the boron to generate high-LET radiation, which may destroy the cancer cells. One to two BNCT treatment sessions may be sufficient to destroy a tumour, while keeping the impact of radiation on surrounding healthy tissue to a minimum.
A research reactor is currently ...
Racial identity tied to happiness, study finds
2011-03-05
EAST LANSING, Mich. — Black people who identify more strongly with their racial identity are generally happier, according to a study led by psychology researchers at Michigan State University.
The study, funded by the National Institute of Mental Health, appears in the current issue of Cultural Diversity and Ethnic Minority Psychology, a research journal published by the American Psychological Association.
"This is the first empirical study we know of that shows a relationship between racial identity and happiness," said Stevie C.Y. Yap, doctoral candidate in psychology ...
LAST 30 PRESS RELEASES:
Insulin resistance is linked to over 30 diseases – and to early death in women, study of people in the UK finds
Innovative semaglutide hydrogel could reduce diabetes shots to once a month
Weight loss could reduce the risk of severe infections in people with diabetes, UK research suggests
Long-term exposure to air pollution and a lack of green space increases the risk of hospitalization for respiratory conditions
Better cardiovascular health in early pregnancy may offset high genetic risk
Artificial intelligence method transforms gene mutation prediction in lung cancer: DeepGEM data releases at IASLC 2024 World Conference on Lung Cancer
Antibody–drug conjugate I-DXd shows clinically meaningful response in patients with extensive-stage small cell lung cancer
IASLC Global Survey on biomarker testing reveals progress and persistent barriers in lung cancer biomarker testing
Research shows pathway to developing predictive biomarkers for immune checkpoint inhibitors
Just how dangerous is Great Salt Lake dust? New research looks for clues
Maroulas appointed Associate Vice Chancellor, Director of AI Tennessee
New chickadee research finds cognitive skills impact lifespan
Cognitive behavioral therapy enhances brain circuits to relieve depression
Terasaki Institute awarded $2.3 Million grant from NIH for organ transplantation research using organs-on-a-chip technology
Atoms on the edge
Postdoc takes multipronged approach to muon detection
Mathematical proof: Five satellites needed for precise navigation
Scalable, multi-functional device lays groundwork for advanced quantum applications
Falling for financial scams? It may signal early Alzheimer’s disease
Integrating MRI and OCT for new insights into brain microstructure
Designing a normative neuroimaging library to support diagnosis of traumatic brain injury
Department of Energy announces $68 million in funding for artificial intelligence for scientific research
DOE, ORNL announce opportunity to define future of high-performance computing
Molecular simulations, supercomputing lead to energy-saving biomaterials breakthrough
Low-impact yoga and exercise found to help older women manage urinary incontinence
Genetic studies reveal new insights into cognitive impairment in schizophrenia
Researcher develops technology to provide cleaner energy and cleaner water
Expect the unexpected: nanoscale silver unveils intrinsic self-healing abilities
nTIDE September 2024 Jobs Report: Gains in employment for people with disabilities appear to level off after reducing gaps with non-disabled workers
Wiley enhances NMR Spectral Library Collection with extensive new databases
[Press-News.org] University of Nevada, Reno, teams with IMMY to make new life-saving blood testNew test hastens diagnosis for Cryptococcosis, top cause of HIV-related deaths in developing countries